A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma
Clinical trial NCT03890666 · COMPLETED
Trial details
- NCT number
- NCT03890666
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-26
- Primary completion
- 2021-10-04
- Enrollment
- 333
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.